Cargando…

JISTIC: Identification of Significant Targets in Cancer

BACKGROUND: Cancer is caused through a multistep process, in which a succession of genetic changes, each conferring a competitive advantage for growth and proliferation, leads to the progressive conversion of normal human cells into malignant cancer cells. Interrogation of cancer genomes holds the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Garcia, Felix, Akavia, Uri David, Mozes, Eyal, Pe'er, Dana
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873534/
https://www.ncbi.nlm.nih.gov/pubmed/20398270
http://dx.doi.org/10.1186/1471-2105-11-189
_version_ 1782181363564150784
author Sanchez-Garcia, Felix
Akavia, Uri David
Mozes, Eyal
Pe'er, Dana
author_facet Sanchez-Garcia, Felix
Akavia, Uri David
Mozes, Eyal
Pe'er, Dana
author_sort Sanchez-Garcia, Felix
collection PubMed
description BACKGROUND: Cancer is caused through a multistep process, in which a succession of genetic changes, each conferring a competitive advantage for growth and proliferation, leads to the progressive conversion of normal human cells into malignant cancer cells. Interrogation of cancer genomes holds the promise of understanding this process, thus revolutionizing cancer research and treatment. As datasets measuring copy number aberrations in tumors accumulate, a major challenge has become to distinguish between those mutations that drive the cancer versus those passenger mutations that have no effect. RESULTS: We present JISTIC, a tool for analyzing datasets of genome-wide copy number variation to identify driver aberrations in cancer. JISTIC is an improvement over the widely used GISTIC algorithm. We compared the performance of JISTIC versus GISTIC on a dataset of glioblastoma copy number variation, JISTIC finds 173 significant regions, whereas GISTIC only finds 103 significant regions. Importantly, the additional regions detected by JISTIC are enriched for oncogenes and genes involved in cell-cycle and proliferation. CONCLUSIONS: JISTIC is an easy-to-install platform independent implementation of GISTIC that outperforms the original algorithm detecting more relevant candidate genes and regions. The software and documentation are freely available and can be found at: http://www.c2b2.columbia.edu/danapeerlab/html/software.html
format Text
id pubmed-2873534
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28735342010-05-20 JISTIC: Identification of Significant Targets in Cancer Sanchez-Garcia, Felix Akavia, Uri David Mozes, Eyal Pe'er, Dana BMC Bioinformatics Software BACKGROUND: Cancer is caused through a multistep process, in which a succession of genetic changes, each conferring a competitive advantage for growth and proliferation, leads to the progressive conversion of normal human cells into malignant cancer cells. Interrogation of cancer genomes holds the promise of understanding this process, thus revolutionizing cancer research and treatment. As datasets measuring copy number aberrations in tumors accumulate, a major challenge has become to distinguish between those mutations that drive the cancer versus those passenger mutations that have no effect. RESULTS: We present JISTIC, a tool for analyzing datasets of genome-wide copy number variation to identify driver aberrations in cancer. JISTIC is an improvement over the widely used GISTIC algorithm. We compared the performance of JISTIC versus GISTIC on a dataset of glioblastoma copy number variation, JISTIC finds 173 significant regions, whereas GISTIC only finds 103 significant regions. Importantly, the additional regions detected by JISTIC are enriched for oncogenes and genes involved in cell-cycle and proliferation. CONCLUSIONS: JISTIC is an easy-to-install platform independent implementation of GISTIC that outperforms the original algorithm detecting more relevant candidate genes and regions. The software and documentation are freely available and can be found at: http://www.c2b2.columbia.edu/danapeerlab/html/software.html BioMed Central 2010-04-14 /pmc/articles/PMC2873534/ /pubmed/20398270 http://dx.doi.org/10.1186/1471-2105-11-189 Text en Copyright ©2010 Sanchez-Garcia et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Software
Sanchez-Garcia, Felix
Akavia, Uri David
Mozes, Eyal
Pe'er, Dana
JISTIC: Identification of Significant Targets in Cancer
title JISTIC: Identification of Significant Targets in Cancer
title_full JISTIC: Identification of Significant Targets in Cancer
title_fullStr JISTIC: Identification of Significant Targets in Cancer
title_full_unstemmed JISTIC: Identification of Significant Targets in Cancer
title_short JISTIC: Identification of Significant Targets in Cancer
title_sort jistic: identification of significant targets in cancer
topic Software
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873534/
https://www.ncbi.nlm.nih.gov/pubmed/20398270
http://dx.doi.org/10.1186/1471-2105-11-189
work_keys_str_mv AT sanchezgarciafelix jisticidentificationofsignificanttargetsincancer
AT akaviauridavid jisticidentificationofsignificanttargetsincancer
AT mozeseyal jisticidentificationofsignificanttargetsincancer
AT peerdana jisticidentificationofsignificanttargetsincancer